Chen Y, Zink T, Chen Y, Nin D, Talmo C, Hollenbeck B
JAMA Netw Open. 2025; 8(3):e250081.
PMID: 40036031
PMC: 11880946.
DOI: 10.1001/jamanetworkopen.2025.0081.
Rashid Z, Woldesenbet S, Khalil M, Altaf A, Kawashima J, Mumtaz K
World J Surg. 2025; 49(3):698-707.
PMID: 39788883
PMC: 11903251.
DOI: 10.1002/wjs.12484.
Arumugam S, Kalagara H
POCUS J. 2024; 9(2):39-41.
PMID: 39640084
PMC: 11619776.
DOI: 10.24908/pocus.v9i2.17700.
Chang M, Ripoll J, Lopez E, Krishnan K, Bittner E
J Clin Med. 2024; 13(21).
PMID: 39518474
PMC: 11546377.
DOI: 10.3390/jcm13216336.
Ghusn W, Hurtado M
Obes Pillars. 2024; 12:100127.
PMID: 39286601
PMC: 11404059.
DOI: 10.1016/j.obpill.2024.100127.
Perioperative Management of Patients with Diabetes and Cancer: Challenges and Opportunities.
Shouman M, Brabant M, Rehman N, Ahmed S, Shahid R
Cancers (Basel). 2024; 16(16).
PMID: 39199594
PMC: 11353093.
DOI: 10.3390/cancers16162821.
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.
Chang M, Bittner E
Can J Anaesth. 2024; 71(9):1302-1315.
PMID: 39187641
DOI: 10.1007/s12630-024-02810-5.
Aspiration under anesthesia: what happens after we sound the glucagon-like peptide-1 receptor agonist alarm?.
Bartoszko J, Van Klei W
Can J Anaesth. 2024; 71(9):1203-1208.
PMID: 39187640
DOI: 10.1007/s12630-024-02809-y.
Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon.
Heckmann N, Palmer R, Mayfield C, Gucev G, Lieberman J, Hong K
Arthroplast Today. 2024; 27:101327.
PMID: 39071832
PMC: 11282421.
DOI: 10.1016/j.artd.2024.101327.
The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis.
do Nascimento T, Pereira R, Maia E, Ohnuma T, da Costa M, Slawka E
Perioper Med (Lond). 2024; 13(1):78.
PMID: 39039540
PMC: 11264430.
DOI: 10.1186/s13741-024-00439-y.
Comment on: Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
Mizubuti G, da Silva L, Silveira S, Gilron I, Ho A
Can J Anaesth. 2024; 71(8):1172-1173.
PMID: 38872002
DOI: 10.1007/s12630-024-02780-8.
A call to update anesthetic protocols: the hidden risks of semaglutide.
Santos L, Nersessian R, Silveira S, Silva L, Matheus G, Buniotti B
Can J Anaesth. 2024; 71(8):1175-1176.
PMID: 38807009
DOI: 10.1007/s12630-024-02774-6.
Rates of glucagon-like peptide-1 receptor agonist use and aspiration events associated with anesthesia at a Canadian academic teaching centre.
Milne A, Berry M, Ellis M, Dobson G
Can J Anaesth. 2024; 71(5):673-675.
PMID: 38589738
DOI: 10.1007/s12630-024-02761-x.
Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
Wu F, Smith M, Mueller A, Klapman S, Everett L, Houle T
Can J Anaesth. 2024; 71(7):958-966.
PMID: 38485835
DOI: 10.1007/s12630-024-02719-z.
The knowns and unknowns of glucagon-like peptide 1 agonists and perioperative care.
McIsaac D, Berrio-Valencia M, Miller E
Can J Anaesth. 2024; 71(7):933-938.
PMID: 38485834
DOI: 10.1007/s12630-024-02718-0.
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity.
Kaur M, Misra S
Eur J Clin Pharmacol. 2024; 80(5):669-676.
PMID: 38367045
DOI: 10.1007/s00228-024-03646-0.
Effects of dietary fibre on metabolic health and obesity.
Deehan E, Mocanu V, Madsen K
Nat Rev Gastroenterol Hepatol. 2024; 21(5):301-318.
PMID: 38326443
DOI: 10.1038/s41575-023-00891-z.
Balancing values: implications of a brain-based definition of death for pluralism in Canada.
Murphy N, Chandler J, Hartwick M, Kanji A, Simpson C, Wilson L
Can J Anaesth. 2023; 70(4):585-590.
PMID: 37147514
PMC: 10203009.
DOI: 10.1007/s12630-023-02408-3.
When is a person dead? The Canadian public's understanding of death and death determination: a nationwide survey.
Sarti A, Honarmand K, Sutherland S, Hornby L, Wilson L, Priestap F
Can J Anaesth. 2023; 70(4):617-627.
PMID: 37131025
PMC: 10202975.
DOI: 10.1007/s12630-023-02409-2.
Answering global challenges to the determination of death: consensus-building leadership from Canada.
Gardiner D, Greer D, Bernat J, Meade M, Opdam H, Schwarz S
Can J Anaesth. 2023; 70(4):468-477.
PMID: 37131024
DOI: 10.1007/s12630-023-02423-4.
